1-12 of 12
Suad Efendić
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes

Henrik Wagner, MD, Marie Degerblad, MD, Anders Thorell, MD, Jonas Nygren, MD, Agneta Ståhle, PHD, Jeanette Kuhl, MD, Torkel B. Brismar, MD, John Öhrvik, PHD, Suad Efendic, MD, Peter N. Båvenholm, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1471–1477
https://doi.org/10.2337/dc05-2513
Published: 01 July 2006
View article titled, Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes
Open the PDF for Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes in another window
Journal Articles

Early Microvascular Dysfunction in Healthy Normal-Weight Males With Heredity for Type 2 Diabetes

Gun Jörneskog, MD, PHD, Majid Kalani, MD, PHD, Jeanette Kuhl, MD, Peter Båvenholm, MD, PHD, Abram Katz, MD, PHD, Gustaf Allerstrand, MD, Michael Alvarsson, MD, PHD, Suad Efendic, MD, PHD, Claes-Göran Östenson, MD, PHD, John Pernow, MD, PHD, John Wahren, MD, PHD, Kerstin Brismar, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(6):1495–1497
https://doi.org/10.2337/diacare.28.6.1495
Published: 01 June 2005
View article titled, Early Microvascular Dysfunction in Healthy Normal-Weight Males With Heredity for Type 2 Diabetes
Open the PDF for Early Microvascular Dysfunction in Healthy Normal-Weight Males With Heredity for Type 2 Diabetes in another window
Journal Articles

Explanations of Socioeconomic Differences in Excess Risk of Type 2 Diabetes in Swedish Men and Women

Emilie E. Agardh, RN, MPH, Anders Ahlbom, PHD, Tomas Andersson, BSC, Suad Efendic, MD, PHD, Valdemar Grill, MD, PHD, Johan Hallqvist, MD, PHD, Claes-Göran Östenson, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(3):716–721
https://doi.org/10.2337/diacare.27.3.716
Published: 01 March 2004
View article titled, Explanations of Socioeconomic Differences in Excess Risk of Type 2 Diabetes in Swedish Men and Women
Open the PDF for Explanations of Socioeconomic Differences in Excess Risk of Type 2 Diabetes in Swedish Men and Women in another window
Journal Articles

Work Stress and Low Sense of Coherence Is Associated With Type 2 Diabetes in Middle-Aged Swedish Women

Emilie E. Agardh, RN, MPH, Anders Ahlbom, PHD, Tomas Andersson, BSC, Suad Efendic, MD, PHD, Valdemar Grill, MD, PHD, Johan Hallqvist, MD, PHD, Anders Norman, MD, Claes-Göran Östenson, MD, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(3):719–724
https://doi.org/10.2337/diacare.26.3.719
Published: 01 March 2003
View article titled, Work Stress and Low Sense of Coherence Is Associated With Type 2 Diabetes in Middle-Aged Swedish Women
Open the PDF for Work Stress and Low Sense of Coherence Is Associated With Type 2 Diabetes in Middle-Aged Swedish Women in another window
Journal Articles

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Bo Ahrén, MD, PHD, Erik Simonsson, MD, Hillevi Larsson, MD, PHD, Mona Landin-Olsson, MD, PHD, Hlin Torgeirsson, MD, Per-Anders Jansson, MD, PHD, Madeléne Sandqvist, MD, Peter Båvenholm, MD, PHD, Suad Efendic, MD, PHD, Jan W. Eriksson, MD, PHD, Sheila Dickinson, MSC, David Holmes, MD
Journal: Diabetes Care
Diabetes Care 2002;25(5):869–875
https://doi.org/10.2337/diacare.25.5.869
Published: 01 May 2002
View article titled, Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes
Open the PDF for Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes in another window
Journal Articles

The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients

Lisa Juntti-Berggren, MD, PHD, Jan Pigon, MD, PHD, Fredrik Karpe, MD, PHD, Anders Hamsten, MD, PHD, Mark Gutniak, MD, PHD, Louis Vignati, MD, Suad Efendic, MD, PHD
Journal: Diabetes Care
Diabetes Care 1996;19(11):1200–1206
https://doi.org/10.2337/diacare.19.11.1200
Published: 01 November 1996
View article titled, The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients
Open the PDF for The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients in another window
Journal Articles

Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas

Mark K Gutniak, MD, PHD, Lisa Juntti-Berggren, MD, PHD, Per M Hellström, MD, PHD, Amel Guenifi, MD, Jens J Holst, MD, PHD, Suad Efendic, MD
Journal: Diabetes Care
Diabetes Care 1996;19(8):857–863
https://doi.org/10.2337/diacare.19.8.857
Published: 01 August 1996
View article titled, Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas
Open the PDF for Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas in another window
Journal Articles

Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMI

Klas A Malmberg, MD, Suad Efendic, MD, PHD, Lars E Rydén, MD, PHD, For The Multicenter Study Group
Journal: Diabetes Care
Diabetes Care 1994;17(9):1007–1014
https://doi.org/10.2337/diacare.17.9.1007
Published: 01 September 1994
View article titled, Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMI
Open the PDF for Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMI in another window
Journal Articles

Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM

Mark K Gutniak, MD, PHD, Birgitta Linde, MD, PHD, Jens J Holst, MD, PHD, Suad Efendić, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(9):1039–1044
https://doi.org/10.2337/diacare.17.9.1039
Published: 01 September 1994
View article titled, Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM
Open the PDF for Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM in another window
Journal Articles

Effects of Combination Therapy With Glyburide and Insulin on Serum Lipid Levels in NIDDM Patients With Secondary Sulfonylurea Failure

Sven G Karlander, MD, Mark KM Gutniak, MD, Suad Efendic, MD
Journal: Diabetes Care
Diabetes Care 1991;14(11):963–967
https://doi.org/10.2337/diacare.14.11.963
Published: 01 November 1991
View article titled, Effects of Combination Therapy With Glyburide and Insulin on Serum Lipid Levels in NIDDM Patients With Secondary Sulfonylurea Failure
Open the PDF for Effects of Combination Therapy With Glyburide and Insulin on Serum Lipid Levels in NIDDM Patients With Secondary Sulfonylurea Failure in another window
Journal Articles

Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea

Mark Gutniak, MD, Sven-Gunnar Karlander, MD, Suad Efendić, MD
Journal: Diabetes Care
Diabetes Care 1987;10(5):545–554
https://doi.org/10.2337/diacare.10.5.545
Published: 01 September 1987
View article titled, Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea
Open the PDF for Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea in another window
Journal Articles

On the Pathogenesis of Maturity-Onset Diabetes

Rolf Luft, Alexandre Wajngot, Suad EfendiĆ
Journal: Diabetes Care
Diabetes Care 1981;4(1):58–63
https://doi.org/10.2337/diacare.4.1.58
Published: 01 January 1981
View article titled, On the Pathogenesis of Maturity-Onset Diabetes
Open the PDF for On the Pathogenesis of Maturity-Onset Diabetes in another window